2012 - IHE

Anderberg EA, Steen Carlsson K and Berntorp K Use of healthcare resources after gestational diabetes mellitus: a longitudinal case-control analysis Scandinavian Journal of Public Health 2012 Jun; 40(4): 385-90
DOI: 10.1177/1403494812449923
Persson U, Svensson J and Pettersson B A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing Applied Health Economics and Health Policy 2012; 10(4): 217-25
DOI: 10.2165/11633930-000000000-00000.
Svensson J, Ghatnekar O, Lindgren A, Lindvall O, Norrving B, Persson U and Kokaia Z Societal Value of Stem Cell Therapy in Stroke – A Modeling Study Cerebrovascular Diseases, 2012; 33(6): 532-539
DOI: 10.1159/000337765
Thorsén F, Rosberg H-E, Steen Carlsson K and Dahlin L B Digital nerve injuries: Epidemiology, results, costs, and impact on daily life Journal of Plastic Surgery and Hand Surgery, 2012; 46(3-4): 184-90
DOI: 10.3109/2000656X.2012.676554
Ghatnekar O, Ljungberg A, Wirestrand LE and Svensson A Costs and quality of life for psoriatic patients at different degrees of severity in southern Sweden – a cross-sectional study European Journal of Dermatology 2012 Mar-Apr; 22(2): 238-45
DOI: 10.1684/ejd.2011.1635
Norlin J M, Steen Carlsson K, Persson U and Schmitt-Egenolf M Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients British Journal of Dermatology 2012; 166(4): 797-802
DOI: 10.1111/j.1365-2133.2011.10778.x
Lökk J, Borg S, Svensson J, Persson U and Ljunggren G Drug and treatment costs in Parkinson´s disease patients in Sweden Acta Neurologica Scandinavica 2012 Feb; 125(2): 142-7
DOI: 10.1111/j.1600-0404.2011.01517.x
Asseburg C, Willis M, Löthgren M, Seppälä N, Hakala M and Persson U Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection Schizophrenia Research and Treatment 2012; Volume 2012, Article ID 791468, 9 pages
DOI: 10.1155/2012/791468

Back »